Literature DB >> 21880706

Chemical genetics of zipper-interacting protein kinase reveal myosin light chain as a bona fide substrate in permeabilized arterial smooth muscle.

Lori D Moffat1, Shannon B A Brown, Michael E Grassie, Annegret Ulke-Lemée, Laura M Williamson, Michael P Walsh, Justin A MacDonald.   

Abstract

Zipper-interacting protein kinase (ZIPK) has been implicated in Ca(2+)-independent smooth muscle contraction, although its specific role is unknown. The addition of ZIPK to demembranated rat caudal arterial strips induced an increase in force, which correlated with increases in LC(20) and MYPT1 phosphorylation. However, because of the number of kinases capable of phosphorylating LC(20) and MYPT1, it has proven difficult to identify the mechanism underlying ZIPK action. Therefore, we set out to identify bona fide ZIPK substrates using a chemical genetics method that takes advantage of ATP analogs with bulky substituents at the N(6) position and an engineered ZIPK capable of utilizing such substrates. (32)P-Labeled 6-phenyl-ATP and ZIPK-L93G mutant protein were added to permeabilized rat caudal arterial strips, and substrate proteins were detected by autoradiography following SDS-PAGE. Mass spectrometry identified LC(20) as a direct target of ZIPK in situ for the first time. Tissues were also exposed to 6-phenyl-ATP and ZIPK-L93G in the absence of endogenous ATP, and putative ZIPK substrates were identified by Western blotting. LC(20) was thereby confirmed as a direct target of ZIPK; however, no phosphorylation of MYPT1 was detected. We conclude that ZIPK is involved in the regulation of smooth muscle contraction through direct phosphorylation of LC(20).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880706      PMCID: PMC3196122          DOI: 10.1074/jbc.M111.257949

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Identification of new JNK substrate using ATP pocket mutant JNK and a corresponding ATP analogue.

Authors:  H Habelhah; K Shah; L Huang; A L Burlingame; K M Shokat; Z Ronai
Journal:  J Biol Chem       Date:  2001-03-19       Impact factor: 5.157

2.  Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase.

Authors:  M Koyama; M Ito; J Feng; T Seko; K Shiraki; K Takase; D J Hartshorne; T Nakano
Journal:  FEBS Lett       Date:  2000-06-23       Impact factor: 4.124

3.  Identification of the endogenous smooth muscle myosin phosphatase-associated kinase.

Authors:  J A MacDonald; M A Borman; A Murányi; A V Somlyo; D J Hartshorne; T A Haystead
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

4.  Zipper-interacting protein kinase induces Ca(2+)-free smooth muscle contraction via myosin light chain phosphorylation.

Authors:  N Niiro; M Ikebe
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

5.  Ca2+-independent smooth muscle contraction. a novel function for integrin-linked kinase.

Authors:  J T Deng; J E Van Lierop; C Sutherland; M P Walsh
Journal:  J Biol Chem       Date:  2001-02-08       Impact factor: 5.157

6.  Ca2+-independent phosphorylation of myosin in rat caudal artery and chicken gizzard myofilaments.

Authors:  L P Weber; J E Van Lierop; M P Walsh
Journal:  J Physiol       Date:  1999-05-01       Impact factor: 5.182

7.  ZIP kinase identified as a novel myosin regulatory light chain kinase in HeLa cells.

Authors:  M Murata-Hori; F Suizu; T Iwasaki; A Kikuchi; H Hosoya
Journal:  FEBS Lett       Date:  1999-05-14       Impact factor: 4.124

Review 8.  Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases.

Authors:  A P Somlyo; X Wu; L A Walker; A V Somlyo
Journal:  Rev Physiol Biochem Pharmacol       Date:  1999       Impact factor: 5.545

9.  Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase.

Authors:  J Feng; M Ito; K Ichikawa; N Isaka; M Nishikawa; D J Hartshorne; T Nakano
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

10.  Dual Ser and Thr phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by MYPT-associated kinase.

Authors:  J A MacDonald; M Eto; M A Borman; D L Brautigan; T A Haystead
Journal:  FEBS Lett       Date:  2001-03-30       Impact factor: 4.124

View more
  21 in total

1.  Myosin regulatory light chain diphosphorylation slows relaxation of arterial smooth muscle.

Authors:  Cindy Sutherland; Michael P Walsh
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

Review 2.  Myotonic dystrophy kinase-related Cdc42-binding kinases (MRCK), the ROCK-like effectors of Cdc42 and Rac1.

Authors:  Zhuoshen Zhao; Ed Manser
Journal:  Small GTPases       Date:  2015-06-19

3.  Generation and characterization of ATP analog-specific protein kinase Cδ.

Authors:  Varun Kumar; Yi-Chinn Weng; Werner J Geldenhuys; Dan Wang; Xiqian Han; Robert O Messing; Wen-Hai Chou
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.157

4.  Targeting Pim Kinases and DAPK3 to Control Hypertension.

Authors:  David A Carlson; Miriam R Singer; Cindy Sutherland; Clara Redondo; Leila T Alexander; Philip F Hughes; Stefan Knapp; Susan B Gurley; Matthew A Sparks; Justin A MacDonald; Timothy A J Haystead
Journal:  Cell Chem Biol       Date:  2018-07-19       Impact factor: 8.116

5.  Identification of quercitrin as an inhibitor of the p90 S6 ribosomal kinase (RSK): structure of its complex with the N-terminal domain of RSK2 at 1.8 Å resolution.

Authors:  Urszula Derewenda; Mykhaylo Artamonov; Gabriela Szukalska; Darkhan Utepbergenov; Natalya Olekhnovich; Hardik I Parikh; Glen E Kellogg; Avril V Somlyo; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-01-19

6.  Jun kinase-induced overexpression of leukemia-associated Rho GEF (LARG) mediates sustained hypercontraction of longitudinal smooth muscle in inflammation.

Authors:  Othman Al-Shboul; Ancy D Nalli; Divya P Kumar; Ruizhe Zhou; Sunila Mahavadi; John F Kuemmerle; John R Grider; Karnam S Murthy
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-16       Impact factor: 4.249

7.  Signaling through myosin light chain kinase in smooth muscles.

Authors:  Ning Gao; Jian Huang; Weiqi He; Minsheng Zhu; Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

8.  Cross-talk between Rho-associated kinase and cyclic nucleotide-dependent kinase signaling pathways in the regulation of smooth muscle myosin light chain phosphatase.

Authors:  Michael E Grassie; Cindy Sutherland; Annegret Ulke-Lemée; Mona Chappellaz; Enikö Kiss; Michael P Walsh; Justin A MacDonald
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

9.  The dominant protein phosphatase PP1c isoform in smooth muscle cells, PP1cβ, is essential for smooth muscle contraction.

Authors:  Audrey N Chang; Ning Gao; Zhenan Liu; Jian Huang; Angus C Nairn; Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2018-09-05       Impact factor: 5.157

10.  Constitutive phosphorylation of myosin phosphatase targeting subunit-1 in smooth muscle.

Authors:  Ming-Ho Tsai; Audrey N Chang; Jian Huang; Weiqi He; H Lee Sweeney; Minsheng Zhu; Kristine E Kamm; James T Stull
Journal:  J Physiol       Date:  2014-05-16       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.